AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36006877 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative social perception of HCPs
Number of subjects: 5
Study 36006877 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban-rural disparities in access to medical supplies and peer support
Number of subjects: 5
Study 33051045 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthocyanin supplementation (125 mg, three times a day)
Number of subjects: 193
Study 33051045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study 35227790 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional 3-dimensional conformal radiation therapy (CR)
Number of subjects: 84
Study 35227790 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated tomotherapy (TT)
Number of subjects: 84
Study 35227790 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CR and TT
Number of subjects: 84
Study 33203471 — intervention group
Group type: EXPERIMENTAL
Intervention: eMBI (mindmom application)
Number of subjects: 280
Study 33203471 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 280
Study 35383680 — intervention group
Group type: EXPERIMENTAL
Intervention: RPE (ratings of perceived exertion) of 3-4 on the 10-point modified Borg scale
Number of subjects: 48
Study 35383680 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-80% of heart rate reserve (HRR) with heart rate monitored by telemetry
Number of subjects: 48
Study 35383680 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-80% of HRR with a personal HR monitor (HRM)
Number of subjects: 48
Study 35383680 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 48
Study 33792555 — intervention group
Group type: EXPERIMENTAL
Intervention: App-based transitional care (study group)
Number of subjects: 98
Study 33792555 — intervention group
Group type: COMPARATOR
Intervention: Routine telephone follow-up (control group)
Number of subjects: 98
Study 32354952 — intervention group
Group type: EXPERIMENTAL
Intervention: 24% oral sucrose solution (0.8 ml/kg)
Number of subjects: 425
Study 32354952 — intervention group
Group type: COMPARATOR
Intervention: Enteral feed alone
Number of subjects: 425
Study 36073213 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on systemic inflammation markers and conventional risk factors
Number of subjects: 430
Study 34216034 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS targeting L-DLPFC and SM1 simultaneously
Number of subjects: 57
Study 34216034 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS targeting L-DLPFC alone
Number of subjects: 57
Study 34216034 — intervention group
Group type: COMPARATOR
Intervention: tDCS targeting SM1 alone
Number of subjects: 57
Study 34216034 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 57
Study 32213044 — intervention group
Group type: EXPERIMENTAL
Intervention: INT (10 s work: 5 s recovery)
Number of subjects: 14
Study 32213044 — intervention group
Group type: COMPARATOR
Intervention: HICT (12‐30 min, maximal effort, constant load cycle bouts)
Number of subjects: 14
Study 34538500 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal tube insertion attempt
Number of subjects: 2146
Study 34538500 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal intubation attempt
Number of subjects: 2146
Study 32210268 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrambled body stimulus
Number of subjects: 0
Study 32210268 — intervention group
Group type: COMPARATOR
Intervention: Normal layout stimulus
Number of subjects: 0
Study 32210268 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin conductance response
Number of subjects: 0
Study 34921834 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages describing economic consequences of ACEs
Number of subjects: 0
Study 34921834 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages describing racial equity consequences of ACEs
Number of subjects: 0
Study 34921834 — intervention group
Group type: COMPARATOR
Intervention: Control groups receiving messages about ACE prevalence or resilience
Number of subjects: 0
Study 34659415 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal massage with Salvia officinalis
Number of subjects: 60
Study 34659415 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal massage
Number of subjects: 60
Study 34659415 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 34659415 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (abdominal massage with Salvia officinalis, abdominal massage, control)
Number of subjects: 60
Study 36014763 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (1 g/kg BM)
Number of subjects: 12
Study 36014763 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose (1 g/kg BM)
Number of subjects: 12
Study 36014763 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose and Fructose (0.5 g/kg BM each)
Number of subjects: 12
Study 36014763 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralose (0.2 g in 300 mL)
Number of subjects: 12
Study 33563372 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory Flow Accelerator (EFA)
Number of subjects: 50
Study 33563372 — intervention group
Group type: COMPARATOR
Intervention: Positive Expiratory Pressure (PEP)
Number of subjects: 50
Study 32274576 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined physiotherapy and coaching intervention (5 individual coaching sessions plus opening and closing session)
Number of subjects: 65
Study 32274576 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy alone
Number of subjects: 65
Study 34360494 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported physical fitness (overall fitness, cardiorespiratory fitness, muscular strength, flexibility)
Number of subjects: 117
Study 34360494 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater speed-agility
Number of subjects: 117
Study 34360494 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin administration to induce or stimulate labour
Number of subjects: 117
Study 32932304 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicaid patients
Number of subjects: 1245
Study 32932304 — intervention group
Group type: COMPARATOR
Intervention: Private patients
Number of subjects: 1245
Study 32932304 — intervention group
Group type: EXPERIMENTAL
Intervention: Private patients triaged by clinician
Number of subjects: 1245
Study 32932304 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicaid patients triaged by clinician
Number of subjects: 1245
Study 35579605 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 226
Study 35579605 — intervention group
Group type: COMPARATOR
Intervention: Control (no CPAP)
Number of subjects: 226
Study 33674243 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen breathing
Number of subjects: 34
Study 33674243 — intervention group
Group type: COMPARATOR
Intervention: Room air breathing
Number of subjects: 34
Study 32442136 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of smartphones and tablets
Number of subjects: 1086
Study 32442136 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of specific apps or software to support memory
Number of subjects: 1086
Study 32442136 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of smartphones and tablets among caregivers
Number of subjects: 1086
Study 32442136 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of specific apps or software to support memory among caregivers
Number of subjects: 1086
Study 32442136 — intervention group
Group type: COMPARATOR
Intervention: Technophilia in people with dementia/mild cognitive impairment vs caregivers
Number of subjects: 1086
Study 32442136 — intervention group
Group type: COMPARATOR
Intervention: Technology enthusiasm
Number of subjects: 1086
Study 32442136 — intervention group
Group type: COMPARATOR
Intervention: Technology anxiety
Number of subjects: 1086
Study 32442136 — intervention group
Group type: COMPARATOR
Intervention: Technophilia associations in people with dementia/mild cognitive impairment
Number of subjects: 1086
Study 32442136 — intervention group
Group type: COMPARATOR
Intervention: Technophilia associations in caregivers
Number of subjects: 1086
Study 35789257 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimekizumab 160 mg every four weeks
Number of subjects: 206
Study 32805405 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabinoid use
Number of subjects: 151
Study 32805405 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabinoid study
Number of subjects: 151
Study 35182213 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral TAPB with 40 ml of 0.375% ropivacaine
Number of subjects: 58
Study 35182213 — intervention group
Group type: COMPARATOR
Intervention: Control group received 40 ml of 0.9% normal saline
Number of subjects: 58
Study 32980853 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwife-managed clinic service providing diet and exercise education before week 16
Number of subjects: 592
Study 32980853 — intervention group
Group type: COMPARATOR
Intervention: Routine antenatal care (control group)
Number of subjects: 592
Study 32980853 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwife-managed clinic service (No-IVF subgroup)
Number of subjects: 592
Study 32980853 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwife-managed clinic service (overweight group)
Number of subjects: 592
Study 33259430 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultracongruent TKA
Number of subjects: 50
Study 33259430 — intervention group
Group type: COMPARATOR
Intervention: Posterior-stabilized TKA
Number of subjects: 50
Study 33150497 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 15 mg twice daily
Number of subjects: 72
Study 33150497 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (dose-adjusted)
Number of subjects: 72
Study 32960954 — intervention group
Group type: EXPERIMENTAL
Intervention: Index guidance
Number of subjects: 214
Study 32960954 — intervention group
Group type: COMPARATOR
Intervention: Unguided management
Number of subjects: 214
Study 36057884 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmitoylethanolamide (PEA) 600 mg daily for 8 weeks
Number of subjects: 70
Study 36057884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 32962536 — intervention group
Group type: EXPERIMENTAL
Intervention: Twinkle artifact (TA)
Number of subjects: 0
Study 32962536 — intervention group
Group type: COMPARATOR
Intervention: Control (without TA)
Number of subjects: 0
Study 32664962 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (lipophilic)
Number of subjects: 105
Study 32664962 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (hydrophilic)
Number of subjects: 105
Study 32664962 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 35239898 — intervention group
Group type: EXPERIMENTAL
Intervention: Xpert® MTB/RIF assay (Xpert)
Number of subjects: 0
Study 35239898 — intervention group
Group type: EXPERIMENTAL
Intervention: Line probe assay (LPA)
Number of subjects: 0
Study 35239898 — intervention group
Group type: COMPARATOR
Intervention: MGITTM 960 (control)
Number of subjects: 0
Study 33221252 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-minute mindfulness session
Number of subjects: 53
Study 33221252 — intervention group
Group type: COMPARATOR
Intervention: Control track
Number of subjects: 53
Study 32627646 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-persuasion intervention
Number of subjects: 241
Study 32627646 — intervention group
Group type: COMPARATOR
Intervention: Social norms control condition
Number of subjects: 241
Study 32627646 — intervention group
Group type: COMPARATOR
Intervention: Control condition focusing on sense of belongingness
Number of subjects: 241
Study 36143215 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-Solving Treatment (PST) for 8 weeks
Number of subjects: 61
Study 36143215 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-Solving Treatment (PST)
Number of subjects: 61
Study 36143215 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 61
Study 32046311 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) - 7 × 2 min cycling repetitions, 3 days/week for 8 weeks
Number of subjects: 24
Study 32046311 — intervention group
Group type: COMPARATOR
Intervention: Continuous moderate-intensity training - 20-30 min cycling, 3 days/week for 8 weeks
Number of subjects: 24
Study 35361163 — intervention group
Group type: EXPERIMENTAL
Intervention: ROSE group
Number of subjects: 198
Study 35361163 — intervention group
Group type: COMPARATOR
Intervention: Non-ROSE group (Control)
Number of subjects: 198
Study 34008842 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 µg vitamin D3
Number of subjects: 16
Study 34008842 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 µg 25(OH)D3
Number of subjects: 16
Study 32603774 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Isocenter SRS
Number of subjects: 73
Study 32603774 — intervention group
Group type: COMPARATOR
Intervention: Multiple-Isocenter SRS
Number of subjects: 73
Study 36233716 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 115
Study 36233716 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (MDZ)
Number of subjects: 115
Study 36233716 — intervention group
Group type: EXPERIMENTAL
Intervention: High risk for OSA
Number of subjects: 115
Study 34605079 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg
Number of subjects: 660
Study 34605079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 660
Study 33719606 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injections after ultrasound-guided percutaneous lavage (UGPL)
Number of subjects: 132
Study 33719606 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium extraction during UGPL
Number of subjects: 132
Study 33719606 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication created between the calcification and the subacromial bursa during UGPL
Number of subjects: 132
Study 33719606 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower DASH score at 3 months
Number of subjects: 132
Study 33719606 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower DASH score at 6 months
Number of subjects: 132
Study 32035854 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training
Number of subjects: 20
Study 32035854 — intervention group
Group type: COMPARATOR
Intervention: Standard Guide (SG) training
Number of subjects: 20
Study 36501840 — intervention group
Group type: EXPERIMENTAL
Intervention: High cuff pressure (HP: 80% of the arterial occlusion pressure)
Number of subjects: 12
Study 36501840 — intervention group
Group type: COMPARATOR
Intervention: Low cuff pressure (LP: 40% of the arterial occlusion pressure)
Number of subjects: 12
Study 36501840 — intervention group
Group type: EXPERIMENTAL
Intervention: High cuff pressure (HP)
Number of subjects: 12
Study 36501840 — intervention group
Group type: COMPARATOR
Intervention: Low cuff pressure (LP)
Number of subjects: 12
Study 34015952 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported Employment Demonstration (SED) intervention
Number of subjects: 2960
Study 32116250 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation for 18 months
Number of subjects: 275
Study 32116250 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study 33595760 — intervention group
Group type: EXPERIMENTAL
Intervention: Our proposed framework for automatic myocardial segmentation
Number of subjects: 100
Study 33595760 — intervention group
Group type: COMPARATOR
Intervention: U-net (traditional segmentation model)
Number of subjects: 100
Study 33595760 — intervention group
Group type: COMPARATOR
Intervention: U-net + forward (model considering only forward temporal information)
Number of subjects: 100
Study 33595760 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual grading study performance of our framework
Number of subjects: 100
Study 36425395 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific strength training combined with a standard care exercise program
Number of subjects: 41
Study 36425395 — intervention group
Group type: COMPARATOR
Intervention: Standard care exercise program without targeted muscle strengthening
Number of subjects: 41
Study 32415529 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy, social support, and perceived access to exercise
Number of subjects: 0
Study 32415529 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy and perceived access to exercise
Number of subjects: 0
Study 32415529 — intervention group
Group type: EXPERIMENTAL
Intervention: Certain types of social support
Number of subjects: 0
Study 36043887 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 1181
Study 36043887 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1181
Study 33370477 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-party bone marrow–derived MSC infusion
Number of subjects: 20
Study 33370477 — intervention group
Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 20
Study 32344650 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (10,000 UI/day)
Number of subjects: 20
Study 32344650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 35393305 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting (daily time-restricted eating; consuming food for not more than 8 hours/day, fasting for at least 16 hours/day)
Number of subjects: 48
Study 35393305 — intervention group
Group type: COMPARATOR
Intervention: Control group without a particular diet
Number of subjects: 48
Study 35393305 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting
Number of subjects: 48
Study 34489128 — intervention group
Group type: EXPERIMENTAL
Intervention: V114 (15-valent PCV) followed by PPSV23
Number of subjects: 652
Study 34489128 — intervention group
Group type: COMPARATOR
Intervention: PCV13 followed by PPSV23
Number of subjects: 652
Study 34489128 — intervention group
Group type: EXPERIMENTAL
Intervention: V114 followed by PPSV23
Number of subjects: 652
Study 36277980 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation
Number of subjects: 90
Study 36277980 — intervention group
Group type: COMPARATOR
Intervention: Medications
Number of subjects: 90
Study 34021264 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight management intervention (weekly weight management group combining commercial weight loss programme with clinical advice from midwives)
Number of subjects: 598
Study 34021264 — intervention group
Group type: COMPARATOR
Intervention: Usual care and leaflets on diet and physical activity in pregnancy (Control group)
Number of subjects: 598
Study 34021264 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight management intervention
Number of subjects: 598
Study 32349528 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping intervention once a week for four weeks
Number of subjects: 62
Study 32349528 — intervention group
Group type: COMPARATOR
Intervention: Compression stockings for four weeks
Number of subjects: 62
Study 35312012 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 539
Study 33107056 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth apps targeting heart failure patients
Number of subjects: 10
Study 36191268 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2944
Study 33987929 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar coagulator used before suturing to control bleeding
Number of subjects: 50
Study 33987929 — intervention group
Group type: COMPARATOR
Intervention: No bipolar coagulator used
Number of subjects: 50
Study 35259534 — intervention group
Group type: EXPERIMENTAL
Intervention: As-needed use of SABAs plus ICS (beclomethasone dipropionate)
Number of subjects: 0
Study 35259534 — intervention group
Group type: COMPARATOR
Intervention: As-needed use of SABAs alone (albuterol)
Number of subjects: 0
Study 33799795 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (overweight/obese)
Number of subjects: 30
Study 33799795 — intervention group
Group type: COMPARATOR
Intervention: Group 0 (normal weight)
Number of subjects: 30
Study 33092478 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Number of subjects: 3279
Study 36397049 — intervention group
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation (ARP)
Number of subjects: 70
Study 36397049 — intervention group
Group type: COMPARATOR
Intervention: Natural healing
Number of subjects: 70
Study 33875532 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-minute yoga intervention (gentle yoga movements, breathing, and meditation)
Number of subjects: 32
Study 33875532 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual pre-exam routines)
Number of subjects: 32
Study 33875532 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-minute yoga intervention
Number of subjects: 32
Study 34053229 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-point cane for one month
Number of subjects: 50
Study 34053229 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 50
Study 35461201 — intervention group
Group type: EXPERIMENTAL
Intervention: N+‐ANN model for predicting postoperative lymph node metastasis in the training group
Number of subjects: 1231
Study 35461201 — intervention group
Group type: EXPERIMENTAL
Intervention: N+‐ANN model for predicting postoperative lymph node metastasis in the validation group
Number of subjects: 1231
Study 35461201 — intervention group
Group type: EXPERIMENTAL
Intervention: N+‐ANN model for predicting pN staging
Number of subjects: 1231
Study 35461201 — intervention group
Group type: COMPARATOR
Intervention: cN staging
Number of subjects: 1231
Study 32538010 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at lower-he acupoints and front-mu acupoints combined with Tongxieyaofang (TXYF), oral administration of TXYF three times a day, routine acupuncture once a day for four weeks.
Number of subjects: 123
Study 32538010 — intervention group
Group type: COMPARATOR
Intervention: TXYF, oral administration of TXYF three times a day for four weeks.
Number of subjects: 123
Study 32538010 — intervention group
Group type: COMPARATOR
Intervention: Pinaverium bromide, 50 mg, oral administration three times a day for four weeks.
Number of subjects: 123
Study 34741530 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib with FLO (5-fluorouracil, oxaliplatin)
Number of subjects: 78